Preferred Label : Hematuria, benign familial, 1;
Symbol : BFH1;
CISMeF acronym : BFH; TMN;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Thin-basement-membrane nephropathy; TMN; Thin membrane nephropathy; Hematuria, benign familial; BFH;
Description : Benign familial hematuria is an autosomal dominant condition manifest as nonprogressive
isolated microscopic hematuria that does not result in renal failure. It is characterized
pathologically by thinning of the glomerular basement membrane (GBM), and can be considered
the mildest end of the spectrum of renal diseases due to type IV collagen defects
of the basement membrane. The most severe end of the spectrum is represented by Alport
syndrome (301050; 203780, 104200), which results in end-stage renal failure and may
be associated with hearing loss and ocular anomalies (review by Lemmink et al. (1996)).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the collagen, type IV, alpha-3 gene (COL4A4, 120131.0003); Caused by mutation in the collagen, type IV, alpha-3 gene (COL4A3, 120070.0007);
Prefixed ID : #141200;
Origin ID : 141200;
UMLS CUI : C0241908;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)